AI Assistant
Blog
Pricing
Log In
Sign Up
Kürzere Verweildauer bei Epistaxis-Patienten unter Rivaroxaban und Apixaban im Vergleich zu Phenprocoumon
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.